Evidence map›Paper›PMID 37144183›Full record

ArticleHeliyon2023

CILP2: A prognostic biomarker associated with immune infiltration in colorectal cancer.

Xueli Wang, Yu Zhang, Niping Song, Kaiqiang Li, Siyun Lei, Jianwei Wang, Zhen Wang, Wei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xueli WangCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310032, China.
Yu ZhangDepartment of Gastroenterology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Niping SongThe Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Kaiqiang LiCenter for Laboratory Medicine, Allergy Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
Siyun LeiCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310032, China.
Jianwei WangCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310032, China.
Zhen WangCenter for Laboratory Medicine, Allergy Center, Department of Transfusion Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
Wei ZhangCollege of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The function played by cartilage intermediate layer protein 2 (CILP2) between colorectal cancer (CRC) progression and immune response remains unclear, especially with respect to immune cell infiltration and checkpoints.

Indexed as

CILP2Colorectal cancerImmune infiltrationImmune microenvironmentPrognosis

Identifiers

PMID37144183
PMCPMC10151353

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.